Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Tumor Embolization Devices Market from 2026 to 2030?
The market size for tumor embolization devices has experienced robust growth recently. This market is projected to expand from $1587.48 billion in 2025 to $1732.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. Historically, this growth can be attributed to factors such as the broadening of interventional oncology practices, an increase in the occurrence of solid tumors, a rise in the uptake of minimally invasive procedures, the accessibility of sophisticated catheter technologies, and the expanding application of embolization within cancer treatment.
The tumor embolization devices market is anticipated to experience substantial expansion in the coming years. It is projected to reach $2464.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period can be attributed to several factors, including escalating investments in interventional oncology, a heightened demand for combination cancer therapies, the broadening of targeted drug delivery techniques, an increasing emphasis on organ-sparing treatments, and the greater integration of imaging-guided interventions. Key trends anticipated within the same period encompass the growing adoption of targeted embolization therapies, a surge in demand for drug-eluting embolic agents, the expanding application of image-guided embolization procedures, the proliferation of minimally invasive oncology interventions, and an intensified focus on precise tumor targeting.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
What Drivers Are Affecting Demand In The Tumor Embolization Devices Market?
The worldwide increase in cancer diagnoses is anticipated to drive the growth of the tumor embolization devices market during the forecast period. Cancer is a condition defined by the unrestrained multiplication of abnormal cells that possess the capacity to invade or spread to other bodily regions. The escalation in cancer cases is primarily influenced by aging populations, as older individuals face an elevated risk of developing cancer due to accumulated genetic mutations and extended exposure to risk factors. Tumor embolization devices are instrumental in addressing the rising cancer prevalence by offering a targeted, minimally invasive therapeutic approach that restricts blood flow to tumors, effectively impeding their growth and improving patient outcomes. For instance, in 2023, the American Cancer Society Inc., a US-based non-profit health group, documented 1,958,310 new cancer cases diagnosed in the US, marking an increase from more than 1,918,030 new cancer cases in 2022. Therefore, the escalating global cancer incidence rate is projected to significantly enhance demand for the tumor embolization market in the forthcoming years.
Which Segments Are Gaining Traction In The Tumor Embolization Devices Market?
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
Which Trends Are Guiding The Evolution Of The Tumor Embolization Devices Market?
Leading companies in the tumor embolization devices market are intensifying their efforts to launch innovative treatments, such as Eye90, to maximize their market revenue. Eye90 microspheres serve as a Y90 radioembolization device specifically developed for addressing liver tumors, particularly hepatocellular carcinoma. For example, in May 2023, ABK Biomedical, a medical device company based in Canada, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin a multicenter pivotal study involving Eye90 microspheres for hepatocellular carcinoma. Eye90 microspheres represent a cutting-edge Y90 radioembolization technology, produced through a proprietary manufacturing process that ensures microspheres possess a consistent size distribution and a high concentration of radioactivity. These microspheres are engineered to deliver a substantial radiation dose directly to the tumor while minimizing exposure to surrounding healthy tissue.
Who Are The Top-Performing Companies In The Tumor Embolization Devices Market In Recent Years?
Major companies operating in the tumor embolization devices market are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Kaneka Corporation, Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Surefire Medical Inc., Varian Medical Systems Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
How Does The Tumor Embolization Devices Market Perform Across Major Global Regions?
North America was the largest region in the tumor embolization devices market in 2025. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Tumor Embolization Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp
Browse Through More Reports Similar to the Global Tumor Embolization Devices Market 2026, By The Business Research Company
Neurovascular Embolization Devices Global Market Report 2026
Transcatheter Embolization And Occlusion Devices Global Market Report 2026
Uterine Fibroid Embolization Device Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company